Isatuximab

ATC L01FC02 · 10 markets · 23 records

Isatuximab 10 markets · 23 records Forms

US 3 records · 3 strengths

  • 500 mg/25 mLinjectionSarclisa also in GB
  • 100 mg/5 mLinjectionSarclisa also in GB
  • 140 mginjectionSarclisa Escena

GB 3 records · 3 strengths

CA 3 records · 2 strengths

  • 140 mg/1 mLliquidSARCLISA SC
  • 20 mg/1 mLliquidSarclisa

AU 3 records · 3 strengths

  • 500 mginjectionSARCLISA isatuximab 500 mg/25 mL concentrated injection vial unknown
  • 100 mginjectionSARCLISA isatuximab 500 mg/25 mL concentrated injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 2 records · 2 strengths

HK 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名SARCLISA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML ×4

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    SG 1 records · 1 strengths

    TW 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      FR 1 records · 1 strengths

      • 20 mg/1 mLinjectionSARCLISA 20 mg/mL, solution à diluer pour perfusion also in ES
      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.